| RS147398633 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS147398904 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Retinal dystrophy |
| RS1473991269 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS147399432 |
ADNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS147399860 |
EPM2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Intellectual disability |
| RS1474000585 |
EPRS1
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS1474000709 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS147401037 |
MCEE
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency, Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency |
| RS1474013513 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 4 |
| RS1474017319 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia, Citrullinemia type I |
| RS147402171 |
PLOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PLOD2-related disorder |
| RS147402935 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS147403664 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal laminar drusen, Hemolytic uremic syndrome |
| RS147404195 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS147404292 |
SLC1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dicarboxylic aminoaciduria, Dicarboxylic aminoaciduria |
| RS147404477 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Hereditary spastic paraplegia |
| RS147405294 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, MYO5B-related disorder |
| RS1474053113 |
RPS29
|
Health Risk |
Likely pathogenic |
— |
| RS1474054365 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1474055596 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS147405732 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS147405788 |
TRMT5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1474058708 |
IQCB1
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 5, Nephronophthisis |
| RS147406088 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1474061940 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal arterial tortuosity, Brain small vessel disease 1 with or without ocular anomalies |
| RS1474063386 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS147406641 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1R, Atrial septal defect 5 |
| RS147407423 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS147407445 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS1474077825 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1474090446 |
FOXP2
|
Health Risk |
Pathogenic |
Childhood apraxia of speech, Childhood apraxia of speech |
| RS147409148 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS147409450 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Inborn genetic diseases |
| RS147409760 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant vitreoretinochoroidopathy, Retinitis pigmentosa |
| RS1474100681 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1474105130 |
SLC2A10
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1474107442 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS147410912 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS147410975 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS147411159 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease, Gaucher disease |
| RS147411334 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1474115309 |
FLNC
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS147412052 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147412202 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS147412276 |
CRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 9, Inborn genetic diseases |
| RS147412842 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-related disorder |
| RS1474151297 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS147415181 |
DONSON
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1474152110 |
TFAP2B
|
Health Risk |
Pathogenic |
— |
| RS147415451 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal acantholytic epidermolysis bullosa, Woolly hair-skin fragility syndrome |
| RS147415641 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia, Achromatopsia 2 |
| RS147415774 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS147415811 |
ARHGAP31
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGAP31-related disorder, Adams-Oliver syndrome 1 |
| RS147416429 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS147416469 |
WBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1474166605 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS147416761 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS147416890 |
DOLK
|
Health Risk |
Conflicting classifications of pathogenicity |
DK1-congenital disorder of glycosylation, Cardiovascular phenotype |
| RS1474181679 |
CDH3
|
Health Risk |
Pathogenic |
Congenital hypotrichosis with juvenile macular dystrophy, Retinal dystrophy |
| RS1474187970 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypochondroplasia, Hypochondroplasia |
| RS147418835 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS147418905 |
PTPN4
|
Health Risk |
Likely pathogenic |
Papillary renal cell carcinoma type 1, Papillary renal cell carcinoma type 1 |
| RS147419225 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1474195407 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS147419780 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
SZT2-related disorder, SZT2-related disorder |
| RS1474201425 |
MCCC2
|
Health Risk |
Likely pathogenic |
— |
| RS147420365 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS147420731 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
CDHR1-related disorder, CDHR1-related disorder |
| RS147421006 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1474214658 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS147422190 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS147422843 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147423442 |
KRT16
|
Health Risk |
Conflicting classifications of pathogenicity |
Pachyonychia congenita 1, KRT16-related disorder |
| RS147424205 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS1474253061 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS147426329 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Wolman disease |
| RS147426388 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS147426418 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS147426809 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type I |
| RS147426852 |
GDNF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS147427088 |
GGCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS147427207 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS147427999 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1474282888 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1474282972 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS147428518 |
STRA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS1474290508 |
ADAMTS13
|
Health Risk |
Likely pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS147429438 |
POMGNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1474297447 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS147429960 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, ACE-related disorder |
| RS147430035 |
HPS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 5, HPS5-related disorder |
| RS1474301500 |
PPP2R1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS147430470 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
Complement component 5 deficiency, Complement component 5 deficiency |
| RS147430700 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS147431446 |
SLC25A38
|
Health Risk |
Pathogenic/Likely pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS1474317878 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Li-Fraumeni syndrome |
| RS147432138 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, OCA2-related disorder |
| RS147432650 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS147433234 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS147433918 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, LYST-related disorder |